Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Gross Profit (2018 - 2025)

Viemed Healthcare (VMD) has disclosed Gross Profit for 6 consecutive years, with $44.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 22.04% year-over-year to $44.1 million, compared with a TTM value of $155.5 million through Dec 2025, up 16.71%, and an annual FY2025 reading of $155.5 million, up 16.71% over the prior year.
  • Gross Profit was $44.1 million for Q4 2025 at Viemed Healthcare, up from $41.3 million in the prior quarter.
  • Across five years, Gross Profit topped out at $44.1 million in Q4 2025 and bottomed at $17.6 million in Q2 2021.
  • Average Gross Profit over 5 years is $28.0 million, with a median of $28.0 million recorded in 2023.
  • The sharpest move saw Gross Profit crashed 32.02% in 2021, then soared 41.16% in 2023.
  • Year by year, Gross Profit stood at $19.7 million in 2021, then grew by 16.45% to $22.9 million in 2022, then skyrocketed by 40.25% to $32.1 million in 2023, then grew by 12.54% to $36.1 million in 2024, then increased by 22.04% to $44.1 million in 2025.
  • Business Quant data shows Gross Profit for VMD at $44.1 million in Q4 2025, $41.3 million in Q3 2025, and $36.7 million in Q2 2025.